Skip to main content

Advertisement

SpringerLink
Log in

Botulinum Toxin for the Head and Neck: a Review of Common Uses and Recent Trends

  • Use of Botulinum Toxin in Otorhinolaryngology (A D’Souza and CL Ng, Section Editors)
  • Published:
Current Otorhinolaryngology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To provide ENT surgeons with an up-to-date overview of the common cosmetic and non-cosmetic uses of botulinum toxin (BoNT) in the head and neck.

Recent Findings

We present a narrative summary of the pharmacology and commercial preparations; principles of use; cautions, contraindications and adverse effects; common cosmetic applications; common non-cosmetic applications; and recent cosmetic trends in the use of BoNT type A.

Summary

The cosmetic and non-cosmetic applications of BoNT in the head and neck have rapidly expanded in recent years, with excellent outcomes and considerable demand from patients. It is essential for ENT surgeons to have a good awareness of BoNT and its applications to complement their practices for the benefit of their patients. This narrative review provides a concise, comprehensive and up-to-date overview of BoNT applications in the head and neck for today’s ENT surgeon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Smith TJ, Hill KK, Raphael BH. Historical and current perspectives on Clostridium botulinum diversity. Res Microbiol. 2014;166(4):290–302.

    PubMed  Google Scholar 

  2. Münchau A, Bhatia KP. Regular review: uses of botulinum toxin injection in medicine today. BMJ. 2000;320(7228):161–5.

    PubMed  PubMed Central  Google Scholar 

  3. Brin MF, James C, Maltman J. Botulinum toxin type a products are not interchangeable: a review of the evidence. Biologics. 2014;8:227–41.

    PubMed  PubMed Central  CAS  Google Scholar 

  4. Morenilla-Palao C, Planells-Cases R, García-Sanz N, Ferrer-Montiel A. Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem. 2004;279(24):25665–72.

    PubMed  CAS  Google Scholar 

  5. Lowe NJ, Lowe P. Botulinum toxins for facial lines: a concise review. Dermatol Ther (Heildelb). 2012;2(1):14.

    Google Scholar 

  6. Dmochowski R, Chapple C, Nitti VW, Chancellor M, Everaert K, Thompson C, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010;184(6):2416–22.

    PubMed  CAS  Google Scholar 

  7. Soares DJ, Dejoseph LM, Zuliani GF, Liebertz DJ, Patel V-SM. Impact of postreconstitution room temperature storage on the efficacy of incobotulinumtoxinA treatment of dynamic lateral canthus lines. Dermatol Surg. 2015;41(6):712–7.

    PubMed  CAS  Google Scholar 

  8. Hexsel DM, Almeida ATD, Rutowitsch M, Castro IAD, Silveira VLB, Gobatto DO, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type a reconstituted up to six consecutive weeks before application. Dermatol Surg. 2003;29(5):523–9.

    PubMed  Google Scholar 

  9. Liu A, Carruthers A, Cohen JL, Coleman WP, Dover JS, Hanke CW, et al. Recommendations and current practices for the reconstitution and storage of botulinum toxin type a. J Am Acad Dermatol. 2011;67(3):373–8.

    PubMed  Google Scholar 

  10. Jabor MA, Kaushik R, Shayani P, Ruiz-Razura A, Smith BK, Morimoto KW, et al. Efficacy of reconstituted and stored botulinum toxin type a: an electrophysiologic and visual study in the auricular muscle of the rabbit. Plast Reconstr Surg. 2003;111(7):2419–26.

    PubMed  Google Scholar 

  11. Yang GC, Chiu RJ, Gillman GS. Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-week-old Botox. Arch Facial Plast Surg. 2008;10(4):273–9.

    PubMed  Google Scholar 

  12. Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve. 1997;20(S6):146–68.

    Google Scholar 

  13. • Dutta S, Passi D, Singh M, Singh P, Sharma S, Sharma A. Botulinum toxin the poison that heals: a brief review. Natl J Maxillofac Surg. 2016;7(1):10 This paper raises the growing importance of Botulinum Toxin type B for patients who have acquired antibody resistance to Botulinum Toxin type A.

    PubMed  PubMed Central  Google Scholar 

  14. Cooper L, Lui M, Nduka C. Botulinum toxin treatment for facial palsy: a systematic review. J Plast Reconstr Aesthet Surg. 2017;70(6):833–41.

    PubMed  Google Scholar 

  15. Ltd. AP. BOTOX® COSMETIC (Botulinum Toxin Type A) Purified Neurotoxin Complex (Glabellar Lines). 2001.

  16. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18(1):17–21.

    PubMed  CAS  Google Scholar 

  17. Jaspers GWC, Pijpe J, Jansma J. The use of botulinum toxin type A in cosmetic facial procedures. Int J Oral Maxillofac Surg. 2011;40(2):127–33.

    CAS  Google Scholar 

  18. Cosmetic Surgery National Data Bank: Statistics 2018. Available at: https://www.surgery.org/sites/default/files/ASAPS-Stats2018.pdf. Accessed on 2.4.20.

  19. The Aesthetic Society. 2020 Plastic Surgery Predictions. Available at: https://www.surgery.org/media/news-releases/the-aesthetic-society-unveils-2020-plastic-surgery-predictions. Accessed on 6.4.20.

  20. Carruthers A, Carruthers J, Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg. 2006;31(4):414–22.

    Google Scholar 

  21. Carruthers A, Carruthers J. Eyebrow height after botulinum toxin type a to the glabella. Dermatol Surg. 2007;33(s1):S26–31.

    PubMed  CAS  Google Scholar 

  22. Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg. 2006;31(10):1297–303.

    Google Scholar 

  23. Monheit G, Carruthers A, Brandt F, Rand R. A randomized, double-blind, placebo-controlled study of botulinum toxin type a for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg. 2007;33(s1):S51–9.

    PubMed  CAS  Google Scholar 

  24. Monheit G, Lin X, Nelson D, Kane M. Consideration of muscle mass in glabellar line treatment with botulinum toxin type A. J Drugs Dermatol. 2012;11(9):1041–5.

    PubMed  CAS  Google Scholar 

  25. Flynn TC. Botulinum Toxin: examining duration of effect in facial aesthetic applications. Am J Clin Dermatol. 2010;11(3):183–99.

    PubMed  Google Scholar 

  26. Mandavia R, Dessouky O, Dhar V, D’Souza A. The use of botulinum toxin in otorhinolaryngology: an updated review. Clin Otolaryngol. 2014;39(4):203–9.

    PubMed  CAS  Google Scholar 

  27. Ascher B, Rzany BJ, Grover R. Efficacy and safety of botulinum toxin type a in the treatment of lateral crowʼs feet. Dermatol Surg. 2009;35(10):1478–86.

    PubMed  CAS  Google Scholar 

  28. Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N, et al. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type a in subjects with Crow’s feet. Dermatol Surg. 2006;31(3):257–62.

    Google Scholar 

  29. Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type a and placebo in patients with crow’s feet. J Am Acad Dermatol. 2002;47(6):834–40.

    PubMed  Google Scholar 

  30. Tamura BM, Odo MY, Chang B, Cucé LC, Flynn TC. Treatment of nasal wrinkles with botulinum toxin. Dermatol Surg. 2006;31(3):271–5.

    Google Scholar 

  31. Semchyshyn N, Sengelmann R. Botulinum Toxin A Treatment of Period Rhytides. Dermatologic Surgery 2003;29(5):490-495

  32. Wu DC, Fabi SG, Goldman MP. Neurotoxins: current concepts in cosmetic use on the face and neck--lower face. Plast Reconstr Surg. 2015;136(5 Suppl):76S–9S.

    CAS  Google Scholar 

  33. Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaén P, et al. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood unit)--part II: wrinkles on the middle and lower face, neck and chest. J Eur Acad Dermatol Venereol. 2010;24(11):1285–95.

    PubMed  CAS  Google Scholar 

  34. Becker-Wegerich PM, Rauch L, Ruzicka T. Botulinum Toxin A. Dermatol Surg. 2002;28(2):168–71.

    PubMed  Google Scholar 

  35. Hwang W-S, Hur M-S, Hu K-S, Song W-C, Koh K-S, Baik H-S, et al. Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin. Angle Orthod. 2009;79(1):70–7.

    PubMed  Google Scholar 

  36. Duruel O, Ataman-Duruel ET, Berker E, Tözüm TF. Treatment of various types of gummy smile with botulinum toxin-A. J Craniofac Surg. 2019;30(3):876–8.

    PubMed  Google Scholar 

  37. • Cohn JE, Greco TM. Advanced Techniques for the Use of Neurotoxins in Non-Surgical Facial Rejuvenation. Aesthetic Plastic Surg 2020. https://doi.org/10.1007/s00266-020-01691-5. This up to date review of the use of neurotoxins in non-surgical facial rejuvenation concludes that toxin can be used to recontour facial proportions, increase symmetry and maintain movement control.

  38. Feily A, Fallahi H, Zandian D, Kalantar H. A succinct review of botulinum toxin in dermatology; update of cosmetic and noncosmetic use. J Cosmet Dermatol. 2011;10(1):58–67.

    PubMed  Google Scholar 

  39. Remigio AFDN, Salles AG, de Faria JCM, Ferreira MC. Comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA at the 1. Plast Reconstr Surg. 2015;135(1):239–49.

    CAS  Google Scholar 

  40. Monini S, Carlo AD, Biagini M, Buffoni A, Volpini L, Lazzarino AI, et al. Combined protocol for treatment of secondary effects from facial nerve palsy. Acta Otolaryngol. 2011;131(8):882–6.

    PubMed  CAS  Google Scholar 

  41. Jowett N, Hadlock TA. A contemporary approach to facial reanimation. JAMA Facial Plast Surg. 2015;17(4):293–300.

    PubMed  Google Scholar 

  42. Cillino S, Raimondi G, Guépratte N, Damiani S, Cillino M, Pace FD, et al. Long-term efficacy of botulinum toxin a for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. Eye (Lond). 2009;24(4):600–7.

    Google Scholar 

  43. Ziade M, Domergue S, Batifol D, Jreige R, Sebbane M, Goudot P, et al. Use of botulinum toxin type a to improve treatment of facial wounds: a prospective randomised study. J Plast Reconstr Aesthet Surg. 2013;66(2):209–14.

    PubMed  Google Scholar 

  44. Xie S, Wang K, Xu T, Guo X-S, Shan X-F, Cai Z-G. Efficacy and safety of botulinum toxin type a for treatment of Frey’s syndrome: evidence from 22 published articles. Cancer Med. 2015;4(11):1639–50.

    PubMed  PubMed Central  Google Scholar 

  45. Jansen S, Jerowski M, Ludwig L, Fischer-Krall E, Beutner D, Grosheva M. Botulinum toxin therapy in Frey’s syndrome: a retrospective study of 440 treatments in 100 patients. Clin Otolaryngol. 2016;42(2):295–300.

    PubMed  Google Scholar 

  46. Vashishta R, Nguyen SA, White DR, Gillespie MB. Botulinum toxin for the treatment of sialorrhea: a meta-analysis. Otolaryngol Head Neck Surg. 2012;148(2):191–6.

    PubMed  Google Scholar 

  47. Torres MAF, Aytés LB, Escoda CG. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal. 2007;12(7):E511–7.

    Google Scholar 

  48. Jost WH, Bäumer T, Laskawi R, Slawek J, Spittau B, Steffen A, et al. Therapy of sialorrhea with botulinum neurotoxin. Neurol Ther. 2019;8(2):273–88.

    PubMed  PubMed Central  Google Scholar 

  49. Kinkelin I, Hund M, Naumann M, Hamm H. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol. 2000;143(4):824–7.

    PubMed  CAS  Google Scholar 

  50. Penney SE, Bruce IA, Saeed SR. Botulinum toxin is effective and safe for palatal tremor. J Neurol. 2006;253(7):857–60.

    PubMed  CAS  Google Scholar 

  51. Slengerik-Hansen J, Ovesen T. Botulinum Toxin treatment of objective tinnitus because of essential palatal tremor: a systematic review. Otol Neurotol. 2016;37(7):820–8.

    PubMed  Google Scholar 

  52. Blitzer A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series: spasmodic dysphonia and botulinum toxin. Eur J Neurol. 2010;17(s1):28–30.

    PubMed  Google Scholar 

  53. Woodson G, Hochstetler H, Murry T. Botulinum toxin therapy for abductor spasmodic dysphonia. J Voice. 2006;20(1):137–43.

    PubMed  Google Scholar 

  54. Orloff LA, Goldman SN. Vocal fold granuloma: successful treatment with botulinum toxin. Otolaryngol Head Neck Surg. 1999;121(4):410–3.

    PubMed  CAS  Google Scholar 

  55. Terré R, Panadés A, Mearin F. Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke. Neurogastroenterol Motil. 2013;25(11):896–e702.

    PubMed  Google Scholar 

  56. Chiu M-J, Chang Y-C, Hsiao T-Y. Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review. Dysphagia. 2004;19(1):52–7.

    PubMed  Google Scholar 

  57. Uygur S, Eryilmaz T, Bulam H, Yavuzer R, Latifoglu O. The quantitative effect of botulinum toxin a over brow height. J Craniofac Surg. 2013;24(4):1285–7.

    PubMed  Google Scholar 

  58. Maas CS, Kim EJ. Temporal brow lift using botulinum toxin A: an update. Plast Reconstr Surg. 2003;112(5 Suppl):109S–12S discussion 113S–114S.

    PubMed  Google Scholar 

  59. Cigna E, Sorvillo V, Stefanizzi G, Fino P, Tarallo M. The use of botulinum toxin in the treatment of plunging nose: cosmetic results and a functional serendipity. Clin Ter. 2013;164(2):e107–13.

    PubMed  CAS  Google Scholar 

  60. Redaelli A. Medical rhinoplasty with hyaluronic acid and botulinum toxin a: a very simple and quite effective technique. J Cosmet Dermatol. 2008;7(3):210–20.

    PubMed  Google Scholar 

  61. Goldman A, Wollina U. Elevation of the corner of the mouth using botulinum toxin type A. J Cutan Aesthet Surg. 2010;3(3):145–50.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dr. Tatiana Aesthetic Dermatology Clinic, 35 Devonshire Place, London, W1G6JP, UK

    Tatiana Lapa & Rishi Mandavia

  2. Gentile Facial Plastic & Aesthetic Laser Center, Youngstown, OH, USA

    Richard Gentile

Authors
  1. Tatiana Lapa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rishi Mandavia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Gentile
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tatiana Lapa.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Use of Botulinum Toxin in Otorhinolaryngology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lapa, T., Mandavia, R. & Gentile, R. Botulinum Toxin for the Head and Neck: a Review of Common Uses and Recent Trends. Curr Otorhinolaryngol Rep 8, 329–335 (2020). https://doi.org/10.1007/s40136-020-00307-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40136-020-00307-5

Keywords

Search

Navigation